Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Healthcare IT

PUBLISHER: Roots Analysis | PRODUCT CODE: 1215502

Cover Image

PUBLISHER: Roots Analysis | PRODUCT CODE: 1215502

Investor Series: Opportunities in Women's Digital Health Market

PUBLISHED:
PAGES: 174 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 1899
PDF (One-Location Site License)
USD 3499
PDF (Department License)
USD 4599
PDF (Enterprise License)
USD 5999

Add to Cart

Description

Table of Contents

List of Tables

INTRODUCTION

Digital health is a broad concept that encompasses telemedicine, teleconsultation, remote monitoring, connected devices, digital health platforms and health applications. The outbreak of COVID-19 pandemic has propelled the usage of digital technologies in order to receive healthcare, remotely. The revolutionary developments in digital health have transformed medicine and biomedical science as well as promoted early disease diagnosis and treatment. , In addition, several FemTech startups are focused on the development of products or offering services to women of all age groups dealing with issues related to pregnancy, periods and menopause. Owing to the increased adoption rate of digital solutions and rise in the demand for remote healthcare services, the companies involved in the women's digital health domain have witnessed a surge in the investment activity, with capital investments worth more than USD 3 billion over the past few years. This has enabled the overall FemTech business to flourish. It is worth noting that, NC° Birth Control, developed by Natural Cycles, was the first application to receive approval from US FDA in 2018 and is CE marked in Europe. This application can be used as a method of contraception and to track menstrual cycles, regularly. Subsequently, in 2021, various other women's digital health solutions received US FDA approvals, including Ava Fertility Tracker (first approved fertility tracking wearable) and Clue (period tracking and birth control app).

Currently, more than 200 women's digital health solutions, including applications / software, wearable devices, and services have been marketed / are under development with applications across various therapeutic areas including, reproductive health / fertility, menstrual cycle, general wellness, pelvic care and fetal health. These digital health solutions provide motivational support and inculcate healthy lifestyle changes in the target patient population. In addition, by advocating more personalized and meaningful treatment for women, employers may advance health equity and aid in the eradication of healthcare inequities. Given the increasing research efforts and active involvement of investors, we anticipate the development of a variety of applications and devices focused on improving women's health, in the coming years. Further, taking into consideration both the historical and contemporary scenarios, we believe that the women's digital health market presents lucrative investment opportunities for both short and long term investors.

SCOPE OF THE REPORT

"The Investor Series: Opportunities in Women's Digital Health Market (Focus on Innovator Landscape, Analysis of Product Offerings and Company Health Indexing, Value Proposition Analysis, Company Competitiveness Analysis, Insights from Historical Funding and Investment Activity, Financial Analysis of Key Public Ventures, Market Forecast and Opportunity Analysis, Key Acquisition Targets, Business Risk Assessment and Return on Investments)" report provides detailed information on the women's digital health market, covering the core and peripheral women's digital health solutions. It offers a technical and financial perspective on how the opportunity in this domain is likely to evolve, in terms of future business success, over the coming decade. The information in this report has been presented across multiple deliverables, featuring MS Excel sheets (some of which include interactive elements) and a MS PowerPoint deck, which summarizes the key takeaways from the project and insights drawn from the curated data. Amongst other elements, the report includes:

  • An introduction to women's digital health, highlighting some of the key application areas of the FemTech industry. It features various types of women's digital health products / solutions that have either been marketed / are under development. In addition, the report highlights prominent barriers to the development and success of women's digital health solutions, and the opinions of representatives from key stakeholder companies involved in this domain.
  • A detailed analysis of women's digital health focused companies that were established post-2006, featuring key insights on the observed trends related to the basic company parameters, such as year of establishment, location of headquarters, company size, and type of venture.
  • An assessment of the various products / solutions, offered by the innovator companies, featuring analysis based on number and types of products. Based on the aforementioned insights, we have developed a quantitative perspective on the relative health (based on the company details, product portfolio, financing activity, estimated revenues and profits) of the different innovator companies that have been described in detail in this report. This analysis is based on a proprietary scoring criterion, informed via secondary research.
  • An informed perspective on the value proposition of the companies captured in the report based on multiple relevant aspects, namely product-related value, value to patients, developer value and outreach-related value.
  • A company competitiveness analysis, which offers a quantitative basis for comparing the strengths / contributions of various industry stakeholders that are involved in providing women's digital health solutions. It is worth mentioning that this analysis is based on the insights generated from the abovementioned relative health indexing and value proposition analysis.
  • A detailed analysis of the funding and investment activity that has taken place in this domain, since 2011. It also includes category-wise financing trends, describing the relative maturity (in terms of number of funding instances and total capital raised) of the innovator companies mentioned in the report. Further, it features a list of the leading investors in women's digital health, based on their participation in financing activity in this industry segment.
  • An elaborate review of the overall women's digital health market from a financial perspective, including detailed fundamental (insights from the balance sheet and key financial ratios) and technical analysis (insights from historical and recent stock price variations as well as analysis using popular stock performance indicators) of financial data of the publicly listed companies within the innovators landscape dataset.
  • A key acquisition targets analysis, based on the insights generated during the course of this study, highlighting some of the promising early-to-mid stage business ventures that are likely to be acquired / merged.
  • A case study on the assessment of business risks, based on some of the major risk categories that are usually discussed in the industry, namely operations-related risks, business-related risks, financial / asset-related risks, product / technology risks, and others (social, economic, environmental and political risks).
  • A case study where investors have exited various women's digital health-related ventures, offering insights on return on investments received (based on availability of data). Leveraging the abovementioned details, the report offers an informed opinion on the future outlook for investors in the women's digital health market.

One of the key objectives of the report was to identify the primary growth drivers and estimate the future growth opportunity associated with the women's digital health market, over the coming decades. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, for the period 2023-2035. Our year-wise projections of the current and future opportunity within the women's digital health market have further been segmented across type of solution (applications / software, devices and services), therapeutic application area (fetal health, general wellness, menstrual cycle, pelvic care and reproductive health / fertility), and geography (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America). In order to account for future uncertainties in the market and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. The information is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been validated from multiple sources of information.

The secondary sources of information include:

  • Annual reports
  • Investor presentations
  • SEC filings
  • Industry databases
  • News releases from company websites
  • Government policy documents
  • Industry analysts' views

The insights presented are solely based on our knowledge, research and understanding of the relevant market, as inferred from various primary and secondary sources of information.

CHAPTER OUTLINES

EXCEL DELIVERABLES

  • Spreadsheet I includes details on the companies captured in the report, along with their respective products. It also features proprietary company health indexing analysis, value proposition analysis, insights from a detailed company competitiveness analysis and a list of industry stakeholders that were deemed to be likely targets for mergers / acquisitions, in the near future. In addition, the deliverable includes a summary dashboard, featuring interactive graphical representations of key insights generated from the data collated.
  • Spreadsheet II features a summary dashboard, including interactive graphical representations of some of the key insights related to the capital investments made in the women's digital health domain (since 2011).
  • Spreadsheet III is a collection of multiple MS Excel sheets that provide summaries of insights generated from a detailed fundamental and technical financial analysis, of publicly listed ventures in the innovator companies' dataset.
  • Spreadsheet IV is a summary MS Excel dashboard, offering detailed graphical representations of the contemporary and future opportunity associated with the women's digital health market.
  • Spreadsheet V includes publicly available information on the investments made by selected investors in companies that are now publicly listed. Based on the aforementioned data, we have offered a perspective on the likely return on investments received by the mentioned investors.

POWERPOINT DELIVERABLES

  • Chapter 1: provides a brief summary of the content presented in the report, beginning with the trends associated with the rapidly growing women's digital health market. Further, some of the key benefits associated with women's digital health solutions, have been presented. Finally, the chapter provides an overview of the current scenario, offering a perspective on how, in light of recent funding activity, the market is likely to evolve over the coming years.
  • Chapters 2 and 3: feature brief (pictorial) summaries of the project objectives and approach used for data collection and analysis, in this study.
  • Chapter 4: features an executive summary of the key insights generated from the data and analytical outputs presented in the report.

Section I: Introduction to Women's Digital Health Solutions and Innovators Landscape

  • Chapter 5: presents an introduction to women's digital health, highlighting the background about the origin and evolution of this domain, along with benefits of digital health technologies. It features the key application areas of the FemTech industry, along with opinions of experts, describing various benefits of these therapies, and anticipated future challenges. Further, it includes information on some of the key players that are engaged in this domain. The views presented in this chapter are backed by inputs from representatives of key stakeholder companies (as stated in publicly available articles and validated through primary research). It concludes with a discussion on the prominent barriers to the development and success of women's digital health solutions.
  • Chapter 6: focuses on some of the innovators (companies established post-2006) and features detailed analysis of such companies. It highlights important company related details, such as year of establishment, headquarters, company size, and type of venture.
  • Chapter 7: includes information on the various products / solutions offered by the companies captured in the report (listed in Chapter 6). Further, it features analysis based on number and types of products. Based on the aforementioned insights and details presented in Chapter 6, we have developed a quantitative perspective on the relative health (based on the company details, product portfolio, financing activity and estimated revenues and profits) of the different innovator companies.
  • Chapter 8: offers an informed perspective on the apparent value proposition of the companies captured in the report (listed in Chapter 6). Based on multiple relevant inputs (as inferred from publicly disclosed value statements), namely product-related value, value to patients, developer value and outreach-related value we developed an empirical framework to quantify the value proposition of a business.
  • Chapter 9: features a detailed company competitiveness analysis, offering a quantitative basis for comparing the developers of women's digital health solutions captured in this report. It is worth mentioning that the analysis described in this section is based on a proprietary scoring criterion, which was informed via our company health indexing and valuation exercise.

Section II: Analysis of Investments

  • Chapter 10: offers insights from a detailed analysis of the funding and investment activity in this domain, since 2011. It includes category-wise financing trends, describing the relative maturity (in terms of number of funding instances and total capital raised) of the innovator companies discussed in the report.

Section III: Financial Analysis of Key Public Ventures

  • Chapter 11: is modelled in the likeness of an equity research report. It features a review of the overall women's digital health market from a financial perspective and includes detailed fundamental (insights from the balance sheet and key financial ratios) and technical analysis (insights from historical and recent stock price variations as well as analysis using popular stock performance indicators) of financial data of publicly listed companies within the innovator landscape dataset.
  • Chapter 12: includes detailed profiles of the public ventures engaged in the development of women's digital health solutions. Each profile features a brief overview of the company, details on its management team, insight from its balance sheet (if available), information on product / service portfolio, a section on recent developments and key financial details (including company investment highlights, company fundamental and company technical analysis).

Section IV: Market Forecast and Opportunity Analysis

  • Chapter 13: features an insightful market forecast and opportunity analysis, highlighting the estimated current and future size of the overall women's digital health market, during the period 2023-2035. The opportunity has been segregated on the basis of type of solution (applications / software, devices and services), therapeutic application area (fetal health, general wellness, menstrual cycle, pelvic care and reproductive health / fertility), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and North Africa).

Section V: Key Acquisition Targets, Business Risk Assessment and Return on Investments

  • Chapter 14: offers insights from a proprietary analysis that leverages inputs from the startup health indexing and value proposition analysis (described in Section I), to offer qualitative recommendations on companies that are likely to be perceived as key acquisition targets.
  • Chapter 15: includes a case study on business risk assessment, offering insights encompassing several known categories of risk; these include operations-related risks, business-related risks, financial / asset-related risks, product / technology risks and other risks.
  • Chapter 16: includes a case study wherein the investors have exited various women's digital health-based ventures, offering insights on return on investments received (based on availability of data). The abovementioned estimates / details offer a perspective on how past investments have paid off for investors as company gradually went public, over time.
  • Chapter 17: provides a pictorial summary of the overall project, presenting insights on the market landscape, funding and investment activity, value proposition, key acquisition targets and the market opportunities in women's digital health domain, across different global regions.
  • Chapter 18: is a set of appendices, that contains the table of contents, list of figures, tables, companies and organizations mentioned in the report.
Show more
Product Code: RAIS0107

TABLE OF CONTENTS

EXCEL DELIVERABLES

1. INNOVATORS AND PRODUCTS DATASET

  • 1.1. Analysis Notes
  • 1.2. Innovator Landscape
  • 1.3. Product Landscape
  • 1.4. Value Proposition
  • 1.5. Key Acquisition Targets
  • 1.6. AI - AVII Appendices

2. FUNDING AND INVESTMENT ANALYSIS

  • 2.1. Analysis Notes
  • 2.2. Summary Dashboard
  • 2.3. Capital Investments in Women's Digital Health
  • 2.4 AI - AIV Appendices

3. FUNDAMENTAL AND TECHNICAL FINANCIAL ANALYSIS

The information presented in this analysis is spread across separate MS Excel sheets, which provide information on key financial parameters and competitive insights based on historical and prevalent trends.

4. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 4.1. Analysis Notes
  • 4.2. Market Forecast and Opportunity Analysis: Marketed Products Dataset
  • 4.3. Market Forecast and Opportunity Analysis: Pricing Dataset
  • 4.4. Market Forecast and Opportunity Analysis: Summary
  • 4.5. Market Forecast and Opportunity Analysis: Applications / Software (Base Scenario)
  • 4.6. Market Forecast and Opportunity Analysis: Applications / Software (Conservative Scenario)
  • 4.7. Market Forecast and Opportunity Analysis: Applications / Software (Optimistic Scenario)
  • 4.8. Market Forecast and Opportunity Analysis: Devices (Base Scenario)
  • 4.9. Market Forecast and Opportunity Analysis: Devices (Conservative Scenario)
  • 4.10. Market Forecast and Opportunity Analysis: Devices (Optimistic Scenario)
  • 4.11. Market Forecast and Opportunity Analysis: Services (Base Scenario)
  • 4.12. Market Forecast and Opportunity Analysis: Services (Conservative Scenario)
  • 4.13. Market Forecast and Opportunity Analysis: Services (Optimistic Scenario)
  • 4.14. Market Forecast and Opportunity Analysis: Prevalence
  • 4.15. Market Forecast and Opportunity Analysis: Validation
  • 4.16. Market Forecast and Opportunity Analysis: Population Data
  • 4.17. Market Forecast and Opportunity Analysis: UN World Population Data

5. RETURN ON INVESTMENTS

  • 5.1. Analysis Notes
  • 5.2. Estimated RoI for Investors in Company A. POWERPOINT DELIVERABLE

1. CONTEXT

2. PROJECT OBJECTIVES

3. PROJECT APPROACH

4. EXECUTIVE SUMMARY

Section I: Introduction to Women's Digital Health Solutions and Innovators Landscape

5. THE WOMEN'S DIGITAL HEALTH MARKET

  • 5.1. Overview
  • 5.2. Importance of FemTech Industry
  • 5.3. Digital Solutions focused on Women's Health
  • 5.4. Leading Products and Challenges
  • 5.5. Case Study: Business Success and Decline

6. WOMEN'S DIGITAL HEALTH: INNOVATOR LANDSCAPE

  • 6.1. Methodology
  • 6.2. Innovators in the Women's Digital Health Market
  • 6.3. Analysis of Innovator Landscape
  • 6.4. Concluding Remarks

7. WOMEN'S DIGITAL HEALTH: PRODUCT LANDSCAPE AND COMPANY HEALTH INDEXING

  • 7.1. List of Products
  • 7.2. Analysis of Product Landscape
  • 7.3. Company Health Indexing Methodology
  • 7.4. Company Health Indexing Scoring
  • 7.5. Company Health Indexing

8. VALUE PROPOSITION ANALYSIS

  • 8.1. Overview and Methodology
  • 8.2. Product-related Value
  • 8.3. Value to Patients
  • 8.4. Developer Value
  • 8.5. Outreach-related Value
  • 8.6. Concluding Remarks

9. COMPANY COMPETITIVENESS ANALYSIS

  • 9.1. Overview and Methodology
  • 9.2. Company Competitiveness Analysis

Section II: Analysis of Investments

10. FUNDING AND INVESTMENT ANALYSIS

  • 10.1. Overview
  • 10.2. Analysis by Type of Funding
  • 10.3. Analysis by Geography
  • 10.4. Most Active Players and Popular Investors
  • 10.5. Trends Across Various Funding Categories
  • 10.6. Summary of Funding and Investments

Section III: Financial Analysis of Key Public Ventures

11. FINANCIAL ANALYSIS OF PUBLIC VENTURES

  • 11.1. Fundamental Financial Analysis Overview
    • 11.1.1. Financial Ratios (Interpretation Guide): Liquidity Ratios
    • 11.1.2. Financial Ratios (Interpretation Guide): Financial and Business Risk Ratios
    • 11.1.3. Financial Ratios (Interpretation Guide): Turnover / Efficiency Ratios
    • 11.1.4. Financial Ratios (Interpretation Guide): Profitability Ratios
    • 11.1.5. Financial Ratios (Interpretation Guide): Market Value Ratios
    • 11.1.6. Financial Ratios (Interpretation Guide): Stability Ratios
    • 11.1.7. Case Study 1
    • 11.1.8. Case Study 2
    • 11.1.9. Case Study 3
  • 11.2. Technical Financial Analysis Overview
    • 11.2.1. Technical Indicators (Interpretation Guide): Candlestick Charts
    • 11.2.2. Technical Indicators (Interpretation Guide): Moving Averages
    • 11.2.3. Technical Indicators (Interpretation Guide): Bollinger Band®
    • 11.2.4. Technical Indicators (Interpretation Guide): Relative Strength Index
    • 11.2.5. Technical Indicators (Interpretation Guide): William's R Analysis
    • 11.2.6. Technical Indicators (Interpretation Guide): Moving Average Convergence Divergence
    • 11.2.7. Case Study 1
    • 11.2.8. Case Study 2
    • 11.2.9. Case Study 3

12. COMPANY PROFILES OF PUBLIC VENTURES

  • 12.1. Bonzun
    • 12.1.1. Key Highlights
      • 12.1.1.1. Company Overview
      • 12.1.1.2. Key Executives
      • 12.1.1.3. Insights from Balance Sheet
      • 12.1.1.4. Product / Service Portfolio
      • 12.1.1.5. Recent Developments
    • 12.1.2. Key Financial Details
      • 12.1.2.1. Company Investments
      • 12.1.2.2. Company Fundamentals
      • 12.1.2.3. Company Technicals
  • 12.2. HeraMED
    • 12.2.1. Key Highlights
      • 12.2.1.1. Company Overview
      • 12.2.1.2. Key Executives
      • 12.2.1.3. Insights from Balance Sheet
      • 12.2.1.4. Product / Service Portfolio
      • 12.2.1.5. Recent Developments
    • 12.2.2. Key Financial Details
      • 12.2.2.1. Company Investments
      • 12.2.2.2. Company Fundamentals
      • 12.2.2.3. Company Technicals
  • 12.3. Sera Prognostics
    • 12.3.1. Key Highlights
      • 12.3.1.1. Company Overview
      • 12.3.1.2. Key Executives
      • 12.3.1.3. Insights from Balance Sheet
      • 12.3.1.4. Product / Service Portfolio
      • 12.3.1.5. Recent Developments
    • 12.3.2. Key Financial Details
      • 12.3.2.1. Company Investments
      • 12.3.2.2. Company Fundamentals
      • 12.3.2.3. Company Technicals

Section IV: Market Forecast and Opportunity Analysis

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

  • 13.1. Overview and Methodology
  • 13.2. Global Women's Digital Health Market, 2023-2035
  • 13.3. Distribution Across Key Market Segments
    • 13.3.1. Women's Digital Health Market: Distribution by Type of Solution, 2023 and 2035
      • 13.3.1.1. Women's Digital Health Market for Applications / Software, 2023-2035
      • 13.3.1.2. Women's Digital Health Market for Devices, 2023-2035
      • 13.3.1.3. Women's Digital Health Market for Services, 2023-2035
    • 13.3.2. Women's Digital Health Market: Distribution by Therapeutic Application Area, 2023 and 2035
      • 13.3.2.1. Women's Digital Health Market for Fetal Health, 2023-2035
      • 13.3.2.2. Women's Digital Health Market for General Wellness, 2023-2035
      • 13.3.2.3. Women's Digital Health Market for Menstrual Cycle, 2023-2035
      • 13.3.2.4. Women's Digital Health Market for Pelvic Care, 2023-2035
      • 13.3.2.5. Women's Digital Health Market for Reproductive Health / Fertility, 2023-2035
    • 13.3.3. Women's Digital Health Market: Distribution by Key Geographical Regions, 2023 and 2035
      • 13.3.3.1. Women's Digital Health Market in North America, 2023-2035
      • 13.3.3.2. Women's Digital Health Market in Europe, 2023-2035
      • 13.3.3.3. Women's Digital Health Market in Asia-Pacific, 2023-2035
      • 13.3.3.4. Women's Digital Health Market in Middle East and North Africa, 2023-2035
      • 13.3.3.5. Women's Digital Health Market in Latin America, 2023-2035
  • 13.4. Women's Digital Health Market for Applications / Software, 2023-2035
    • 13.4.1. Women's Digital Health Market for Applications / Software: Distribution by Therapeutic Application Area, 2023 and 2035
      • 13.4.1.1. Women's Digital Health Applications / Software Market for Fetal Health, 2023-2035
      • 13.4.1.2. Women's Digital Health Applications / Software Market for General Wellness, 2023-2035
      • 13.4.1.3. Women's Digital Health Applications / Software Market for Menstrual Cycle, 2023-2035
      • 13.4.1.4. Women's Digital Health Applications / Software Market for Pelvic Care, 2023-2035
      • 13.4.1.5. Women's Digital Health Applications / Software Market for Reproductive Health / Fertility, 2023-2035
    • 13.4.2. Women's Digital Health Market for Applications / Software: Distribution by Key Geographical Regions, 2023 and 2035
      • 13.4.2.1. Women's Digital Health Applications / Software Market in North America, 2023-2035
      • 13.4.2.2. Women's Digital Health Applications / Software Market in Europe, 2023-2035
      • 13.4.2.3. Women's Digital Health Applications / Software Market in Asia-Pacific, 2023-2035
      • 13.4.2.4. Women's Digital Health Applications / Software Market in Middle East and North Africa, 2023-2035
      • 13.4.2.5. Women's Digital Health Applications / Software Market in Latin America, 2023-2035
  • 13.5. Women's Digital Health Market for Devices, 2023-2035
    • 13.5.1. Women's Digital Health Market for Devices: Distribution by Therapeutic Application Area, 2023 and 2035
      • 13.5.1.1. Women's Digital Health Devices Market for Fetal Health, 2023-2035
      • 13.5.1.2. Women's Digital Health Devices Market for General Wellness, 2023-2035
      • 13.5.1.3. Women's Digital Health Devices Market for Menstrual Cycle, 2023-2035
      • 13.5.1.4. Women's Digital Health Devices Market for Pelvic Care, 2023-2035
      • 13.5.1.5. Women's Digital Health Devices Market for Reproductive Health / Fertility, 2023-2035
    • 13.5.2. Women's Digital Health Market for Devices: Distribution by Key Geographical Regions, 2023 and 2035
      • 13.5.2.1. Women's Digital Health Devices Market in North America, 2023-2035
      • 13.5.2.2. Women's Digital Health Devices Market in Europe, 2023-2035
      • 13.5.2.3. Women's Digital Health Devices Market in Asia-Pacific, 2023-2035
      • 13.5.2.4. Women's Digital Health Devices Market in Middle East and North Africa, 2023-2035
      • 13.5.2.5. Women's Digital Health Devices Market in Latin America, 2023-2035
  • 13.6. Women's Digital Health Market for Services, 2023-2035
    • 13.6.1. Women's Digital Health Market for Services: Distribution by Therapeutic Application Area, 2023 and 2035
      • 13.6.1.1. Women's Digital Health Services Market for Fetal Health, 2023-2035
      • 13.6.1.2. Women's Digital Health Services Market for General Wellness, 2023-2035
      • 13.6.1.3. Women's Digital Health Services Market for Menstrual Cycle, 2023-2035
      • 13.6.1.4. Women's Digital Health Services Market for Pelvic Care, 2023-2035
      • 13.6.1.5. Women's Digital Health Services Market for Reproductive Health / Fertility, 2023-2035
    • 13.6.2. Women's Digital Health Market for Services: Distribution by Key Geographical Regions, 2023 and 2035
      • 13.6.2.1. Women's Digital Health Services Market in North America, 2023-2035
      • 13.6.2.2. Women's Digital Health Services Market in Europe, 2023-2035
      • 13.6.2.3. Women's Digital Health Services Market in Asia-Pacific, 2023-2035
      • 13.6.2.4. Women's Digital Health Services Market in Middle East and North Africa, 2023-2035
      • 13.6.2.5. Women's Digital Health Services Market in Latin America, 2023-2035

Section V: Key Acquisition Targets, Business Risk Assessment and Return on Investments

14. KEY ACQUISITION TARGETS

  • 14.1. Overview
  • 14.2. Likely Acquisition Targets

15. BUSINESS RISK ASSESSMENT

  • 15.1. Chapter Overview
  • 15.2. Operations-related Risks
  • 15.3. Business-related Risks
  • 15.4. Financial / Asset-related Risks
  • 15.5. Product / Technology Risks
  • 15.6. Other Risks

16. RETURN ON INVESTMENTS

  • 16.1. Overview and Methodology
  • 16.2. Case Study

17. CONCLUSION

18. APPENDICES

Show more
Product Code: RAIS0107

LIST OF TABLES

  • Table 6.1. List of Innovators in Women's Digital Health Market
  • Table 7.1. List of Products: Information on Current Status of Development and Type of Product(s) / Solution(s)
  • Table 7.2. List of Products: Information on Regulatory Approval(s) and Therapeutic Application Area(s)
  • Table 7.3. List of Products: Information on Usage Period wrt Pregnancy, Purpose(s) and End User(s)
  • Table 7.4. Company Health Indexing: Scoring of Parameters
  • Table 7.5. Company Health Indexing: Leading Innovators
  • Table 8.1. Value Proposition Analysis: Key Values and Scores
  • Table 9.1. Company Competitiveness Analysis: Scoring of Parameters
  • Table 12.1. Bonzun: Insights from Balance Sheet
  • Table 12.2. HeraMED: Insights from Balance Sheet
  • Table 12.3. Sera Prognostics: Insights from Balance Sheet

LIST OF FIGURES

  • Figure 5.1. Women's Digital Health: Benefits of Digital Health Technologies
  • Figure 5.2. Women's Digital Health: Key Application Areas of FemTech Industry
  • Figure 5.3. Women's Digital Health: Type of Product(s) / Solution(s) and Key Industry Players
  • Figure 5.4. Women's Digital Health: Key Marketed Products and Challenges
  • Figure 5.5. Success Story: HeraMED
  • Figure 5.6. Success Story: Sera Prognostics
  • Figure 5.7. Business Decline Story: Bonzun
  • Figure 5.8. Business Decline Story: Braster
  • Figure 6.1. Innovator Landscape: Distribution by Year of Establishment
  • Figure 6.2. Innovator Landscape: Distribution by Type of Venture
  • Figure 6.3. Innovator Landscape: Distribution by Company Size
  • Figure 6.4. Innovator Landscape: Distribution by Type of Market
  • Figure 6.5. Innovator Landscape: Distribution by Number of Products
  • Figure 6.6. Innovator Landscape: Distribution by Geography
  • Figure 7.1. Product Landscape: Distribution by Current Status of Development
  • Figure 7.2. Product Landscape: Distribution by Type of Product(s) / Solution(s)
  • Figure 7.3. Product Landscape: Distribution by Regulatory Approval(s)
  • Figure 7.4. Product Landscape: Distribution by Therapeutic Application Area(s)
  • Figure 7.5. Product Landscape: Distribution by Usage Period wrt Pregnancy
  • Figure 7.6. Product Landscape: Distribution by Purpose(s)
  • Figure 7.7. Product Landscape: Distribution by End User(s)
  • Figure 8.1. Companies Offering Product-related Value: Distribution of Companies by Value Offered and Experience
  • Figure 8.2. Companies Offering Product-related Value: Distribution of Companies Offering Very High Value
  • Figure 8.3. Companies Offering Value to Patients: Distribution of Companies by Value Offered and Experience
  • Figure 8.4. Companies Offering Value to Patients: Distribution of Companies Offering Very High Value
  • Figure 8.5. Companies Offering Developer Value: Distribution of Companies by Value Offered and Experience
  • Figure 8.6. Companies Offering Developer Value: Distribution of Companies Offering Very High Value
  • Figure 8.7. Companies Offering Outreach-related Value: Distribution of Companies by Value Offered and Experience
  • Figure 8.8. Companies Offering Outreach-related Value: Distribution of Companies Offering Very High Value
  • Figure 8.9. Value Proposition Analysis: Concluding Remarks
  • Figure 9.1. Company Competitiveness Analysis: Large Companies based in North America (Peer Group I)
  • Figure 9.2. Company Competitiveness Analysis: Mid-sized Companies based in North America (Peer Group II)
  • Figure 9.3. Company Competitiveness Analysis: Small Companies based in North America (Peer Group III)
  • Figure 9.4. Company Competitiveness Analysis: Very Small Companies based in North America (Peer Group IV)
  • Figure 9.5. Company Competitiveness Analysis: Large and Mid-sized Companies based in Europe (Peer Group V)
  • Figure 9.6. Company Competitiveness Analysis: Small Companies based in Europe (Peer Group VI)
  • Figure 9.7. Company Competitiveness Analysis: Very Small Companies based in Europe (Peer Group VII)
  • Figure 9.8. Company Competitiveness Analysis: Large and Mid-sized Companies based in Asia-Pacific and Rest of the World (Peer Group VIII)
  • Figure 9.9. Company Competitiveness Analysis: Small Companies based in Asia-Pacific and Rest of the World (Peer Group IX)
  • Figure 9.10. Company Competitiveness Analysis: Very Small Companies based in Asia-Pacific and Rest of the World (Peer Group X)
  • Figure 10.1. Funding and Investment Analysis: Cumulative Year-wise Distribution of Funding Instances and Amount Invested, Pre-2013-2022 (USD Million)
  • Figure 10.2. Funding and Investment Analysis: Distribution of Instances by Type of Funding
  • Figure 10.3. Funding and Investment Analysis: Distribution of Instances by Type of Venture Capital Funding
  • Figure 10.4. Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
  • Figure 10.5. Funding and Investment Analysis: Distribution of Amount Invested by Venture Capital Funding (USD Million)
  • Figure 10.6. Funding and Investment Analysis: Geographical Distribution of Funding Instances
  • Figure 10.7. Funding and Investment Analysis: Geographical Distribution of Amount Invested (USD Million)
  • Figure 10.8. Funding and Investment Analysis: Most Active Players by Number of Instances
  • Figure 10.9. Funding and Investment Analysis: Most Active Players by Amount Raised (USD Million)
  • Figure 10.10. Funding and Investment Analysis: Most Active Investors by Number of Instances
  • Figure 10.11. Awards / Grants: Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.12. Awards / Grants: Global Distribution of Amount Invested (USD Million)
  • Figure 10.13. Awards / Grants: Most Active Investors
  • Figure 10.14. Crowd Funding: Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.15. Crowd Funding: Global Distribution of Amount Invested (USD Million)
  • Figure 10.16. Seed Funding: Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.17. Seed Funding: Global Distribution of Amount Invested (USD Million)
  • Figure 10.18. Seed Funding: Most Active Investors
  • Figure 10.19. Venture (Series A): Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.20. Venture (Series A): Global Distribution of Amount Invested (USD Million)
  • Figure 10.21. Venture (Series A): Most Active Investors
  • Figure 10.22. Venture (Series B): Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.23. Venture (Series B): Global Distribution of Amount Invested (USD Million)
  • Figure 10.24. Venture (Series B): Most Active Investors
  • Figure 10.25. Venture (Series C): Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.26. Venture (Series C): Global Distribution of Amount Invested (USD Million)
  • Figure 10.27. Venture (Series C): Most Active Investors
  • Figure 10.28. Venture (Series D): Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.29. Venture (Series D): Global Distribution of Amount Invested (USD Million)
  • Figure 10.30. Venture (Series D): Most Active Investors
  • Figure 10.31. Venture (Series E): Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.32. Venture (Series E): Global Distribution of Amount Invested (USD Million)
  • Figure 10.33. Venture (Series E): Most Active Investors
  • Figure 10.34. Public Offering: Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.35. Public Offering: Global Distribution of Amount Invested (USD Million)
  • Figure 10.36. Private Placement: Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.37. Private Placement: Global Distribution of Amount Invested (USD Million)
  • Figure 10.38. Private Placement: Most Active Investors
  • Figure 10.39. Debt Financing: Cumulative Instances and Amount Invested (USD Million)
  • Figure 10.40. Debt Financing: Global Distribution of Amount Invested (USD Million)
  • Figure 10.41. Debt Financing: Most Active Investors
  • Figure 10.42. Capital Investments in Women's Digital Health: Summary of Investments, 2011-2022
  • Figure 11.1. Fundamental Financial Analysis: Annual Revenues and Key Balance Sheet Parameter-related Trends (Bonzun)
  • Figure 11.2. Fundamental Financial Analysis: Liquidity Ratios, 2-years Trend (Bonzun)
  • Figure 11.3. Fundamental Financial Analysis: Financial, Business Risk and Turnover / Efficiency Ratios, 2-years Trend (Bonzun)
  • Figure 11.4. Fundamental Financial Analysis: Profitability Ratios, 2-years Trend (Bonzun)
  • Figure 11.5. Fundamental Financial Analysis: Market Value and Stability Ratios, 2-years Trend (Bonzun)
  • Figure 11.6. Fundamental Financial Analysis: Annual Revenues and Key Balance Sheet Parameter-related Trends (HeraMED)
  • Figure 11.7. Fundamental Financial Analysis: Liquidity Ratios, 5-years Trend (HeraMED)
  • Figure 11.8. Fundamental Financial Analysis: Financial, Business Risk and Turnover / Efficiency Ratios, 5-years Trend (HeraMED)
  • Figure 11.9. Fundamental Financial Analysis: Profitability Ratios, 5-years Trend (HeraMED)
  • Figure 11.10. Fundamental Financial Analysis: Market Value and Stability Ratios, 5-years Trend (HeraMED)
  • Figure 11.11. Fundamental Financial Analysis: Annual Revenues and Key Balance Sheet Parameter-related Trends (Sera Prognostics)
  • Figure 11.12. Fundamental Financial Analysis: Liquidity Ratios, 3-years Trend (Sera Prognostics)
  • Figure 11.13. Fundamental Financial Analysis: Financial, Business Risk and Turnover / Efficiency Ratios, 3-years Trend (Sera Prognostics)
  • Figure 11.14. Fundamental Financial Analysis: Profitability Ratios, 3-years Trend (Sera Prognostics)
  • Figure 11.15. Fundamental Financial Analysis: Market Value and Stability Ratios, 3-years Trend (Sera Prognostics)
  • Figure 11.16. Technical Analysis: Stock Price (Candlestick Chart) and Volume Traded (Bonzun)
  • Figure 11.17. Technical Analysis: 5-Day Moving Average (Bonzun)
  • Figure 11.18. Technical Analysis: 10-Day Moving Average (Bonzun)
  • Figure 11.19. Technical Analysis: 50-Day Moving Average (Bonzun)
  • Figure 11.20. Technical Analysis: Bollinger Band® (Bonzun)
  • Figure 11.21. Technical Analysis: Relative Strength Index (Bonzun)
  • Figure 11.22. Technical Analysis: Williams' R Analysis (Bonzun)
  • Figure 11.23. Technical Analysis: Moving Average Convergence Divergence (Bonzun)
  • Figure 11.24. Technical Analysis: Stock Price (Candlestick Chart) and Volume Traded (HeraMED)
  • Figure 11.25. Technical Analysis: 5-Day Moving Average (HeraMED)
  • Figure 11.26. Technical Analysis: 10-Day Moving Average (HeraMED)
  • Figure 11.27. Technical Analysis: 50-Day Moving Average (HeraMED)
  • Figure 11.28. Technical Analysis: Bollinger Band® (HeraMED)
  • Figure 11.29. Technical Analysis: Relative Strength Index (HeraMED)
  • Figure 11.30. Technical Analysis: Williams' R Analysis (HeraMED)
  • Figure 11.31. Technical Analysis: Moving Average Convergence Divergence (HeraMED)
  • Figure 11.32. Technical Analysis: Stock Price (Candlestick Chart) and Volume Traded (Sera Prognostics)
  • Figure 11.33. Technical Analysis: 5-Day Moving Average (Sera Prognostics)
  • Figure 11.34. Technical Analysis: 10-Day Moving Average (Sera Prognostics)
  • Figure 11.35. Technical Analysis: 50-Day Moving Average (Sera Prognostics)
  • Figure 11.36. Technical Analysis: Bollinger Band® (Sera Prognostics)
  • Figure 11.37. Technical Analysis: Relative Strength Index (Sera Prognostics)
  • Figure 11.38. Technical Analysis: Williams' R Analysis (Sera Prognostics)
  • Figure 11.39. Technical Analysis: Moving Average Convergence Divergence (Sera Prognostics)
  • Figure 12.1. Bonzun: Company Fundamentals
  • Figure 12.2. Bonzun: Company Technicals
  • Figure 12.3. HeraMED: Company Fundamentals
  • Figure 12.4. HeraMED: Company Technicals
  • Figure 12.5. Sera Prognostics: Company Fundamentals
  • Figure 12.6. Sera Prognostics: Company Technicals
  • Figure 13.1. Global Women's Digital Health Market, 2023-2035 (USD Million)
  • Figure 13.2. Women's Digital Health Market: Distribution by Type of Solution, 2023 and 2035
  • Figure 13.3. Women's Digital Health Market for Applications / Software, 2023-2035 (USD Million)
  • Figure 13.4. Women's Digital Health Market for Devices, 2023-2035 (USD Million)
  • Figure 13.5. Women's Digital Health Market for Services, 2023-2035 (USD Million)
  • Figure 13.6. Women's Digital Health Market: Distribution by Therapeutic Application Area, 2023 and 2035
  • Figure 13.7. Women's Digital Health Market for Fetal Health, 2023-2035 (USD Million)
  • Figure 13.8. Women's Digital Health Market for General Wellness, 2023-2035 (USD Million)
  • Figure 13.9. Women's Digital Health Market for Menstrual Cycle, 2023-2035 (USD Million)
  • Figure 13.10. Women's Digital Health Market for Pelvic Care, 2023-2035 (USD Million)
  • Figure 13.11. Women's Digital Health Market for Reproductive Health / Fertility, 2023-2035 (USD Million)
  • Figure 13.12. Women's Digital Health Market: Distribution by Key Geographical Regions, 2023 and 2035
  • Figure 13.13. Women's Digital Health Market in North America, 2023-2035 (USD Million)
  • Figure 13.14. Women's Digital Health Market in Europe, 2023-2035 (USD Million)
  • Figure 13.15. Women's Digital Health Market in Asia-Pacific, 2023-2035 (USD Million)
  • Figure 13.16. Women's Digital Health Market in Latin America, 2023-2035 (USD Million)
  • Figure 13.17. Women's Digital Health Market in Middle East and North Africa, 2023-2035 (USD Million)
  • Figure 13.18. Women's Digital Health Market for Applications / Software: Distribution by Therapeutic Application Area, 2023 and 2035
  • Figure 13.19. Women's Digital Health Applications / Software Market for Fetal Health, 2023-2035 (USD Million)
  • Figure 13.20. Women's Digital Health Applications / Software Market for General Wellness, 2023-2035 (USD Million)
  • Figure 13.21. Women's Digital Health Applications / Software Market for Menstrual Cycle, 2023-2035 (USD Million)
  • Figure 13.22. Women's Digital Health Applications / Software Market for Pelvic Care, 2023-2035 (USD Million)
  • Figure 13.23. Women's Digital Health Applications / Software Market for Reproductive Health / Fertility, 2023-2035 (USD Million)
  • Figure 13.24. Women's Digital Health Market for Applications / Software: Distribution by Key Geographical Regions, 2023 and 2035
  • Figure 13.25. Women's Digital Health Applications / Software Market in North America, 2023-2035 (USD Million)
  • Figure 13.26. Women's Digital Health Applications / Software Market in Europe, 2023-2035 (USD Million)
  • Figure 13.27. Women's Digital Health Applications / Software Market in Asia-Pacific, 2023-2035 (USD Million)
  • Figure 13.28. Women's Digital Health Applications / Software Market in Latin America, 2023-2035 (USD Million)
  • Figure 13.29. Women's Digital Health Applications / Software Market in Middle East and North Africa, 2023-2035 (USD Million)
  • Figure 13.30. Women's Digital Health Market for Devices: Distribution by Therapeutic Application Area, 2023 and 2035
  • Figure 13.31. Women's Digital Health Devices Market for Fetal Health, 2023-2035 (USD Million)
  • Figure 13.32. Women's Digital Health Devices Market for General Wellness, 2023-2035 (USD Million)
  • Figure 13.33. Women's Digital Health Devices Market for Menstrual Cycle, 2023-2035 (USD Million)
  • Figure 13.34. Women's Digital Health Devices Market for Pelvic Care, 2023-2035 (USD Million)
  • Figure 13.35. Women's Digital Health Devices Market for Reproductive Health / Fertility, 2023-2035 (USD Million)
  • Figure 13.36. Women's Digital Health Market for Devices: Distribution by Key Geographical Regions, 2023 and 2035
  • Figure 13.37. Women's Digital Health Devices Market in North America, 2023-2035 (USD Million)
  • Figure 13.38. Women's Digital Health Devices Market in Europe, 2023-2035 (USD Million)
  • Figure 13.39. Women's Digital Health Devices Market in Asia-Pacific, 2023-2035 (USD Million)
  • Figure 13.40. Women's Digital Health Devices Market in Latin America, 2023-2035 (USD Million)
  • Figure 13.41. Women's Digital Health Devices Market in Middle East and North Africa, 2023-2035 (USD Million)
  • Figure 13.42. Women's Digital Health Market for Services: Distribution by Therapeutic Application Area, 2023 and 2035
  • Figure 13.43. Women's Digital Health Services Market for Fetal Health, 2023-2035 (USD Million)
  • Figure 13.44. Women's Digital Health Services Market for General Wellness, 2023-2035 (USD Million)
  • Figure 13.45. Women's Digital Health Services Market for Menstrual Cycle, 2023-2035 (USD Million)
  • Figure 13.46. Women's Digital Health Services Market for Pelvic Care, 2023-2035 (USD Million)
  • Figure 13.47. Women's Digital Health Services Market for Reproductive Health / Fertility, 2023-2035 (USD Million)
  • Figure 13.48. Women's Digital Health Market for Services: Distribution by Key Geographical Regions, 2023 and 2035
  • Figure 13.49. Women's Digital Health Services Market in North America, 2023-2035 (USD Million)
  • Figure 13.50. Women's Digital Health Services Market in Europe, 2023-2035 (USD Million)
  • Figure 13.51. Women's Digital Health Services Market in Asia-Pacific, 2023-2035 (USD Million)
  • Figure 13.52. Women's Digital Health Services Market in Latin America, 2023-2035 (USD Million)
  • Figure 13.53. Women's Digital Health Services Market in Middle East and North Africa, 2023-2035 (USD Million)
  • Figure 14.1. Key Acquisition Targets: Comparison of Scores with Overall Dataset
  • Figure 14.2. Key Acquisition Targets: Comparison based on Qualifying Parameters
  • Figure 15.1. Business Risk Analysis: Operations-related Risks
  • Figure 15.2. Business Risk Analysis: Business-related Risks
  • Figure 15.3. Business Risk Analysis: Financial / Asset-related Risks
  • Figure 15.4. Business Risk Analysis: Product / Technology Risks
  • Figure 15.5. Business Risk Analysis: Other Risks
  • Figure 16.1. Returns on Investment: Reported by Selected Stakeholders in Sera Prognostics and Historical Funding Activity
  • Figure 17.1. Concluding Landscape: North America
  • Figure 17.2. Concluding Landscape: Europe
  • Figure 17.3. Concluding Landscape: Asia-Pacific
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!